|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute for Biophysics, University of Linz, A-4040 Linz, Austria2 Institute of Pharmacology and Toxicology, University of Graz, A-8010 Graz, Austria3 Membrane Biology Program and Renal Divison, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, MA 02115, USA
CaT1, the calcium transport protein 1 encoded by TRPV6, is able to generate a Ca2+ conductance similar but not identical to the classical CRAC current in mucosal-type mast cells. Here we show that CaT1-derived Ca2+ entry into HEK293 cells is effectively inhibited either by expression of various dominant negative N-terminal fragments of CaT1 (N334-CaT1, N198-CaT1 and N154-CaT1) or by antisense suppression. By contrast, the endogenous CRAC current of the mast cells was unaffected by CaT1 antisense and siRNA knockdown but markedly suppressed by two (N334-CaT1, N198-CaT1) of the dominant negative N-CaT1 fragments. Inhibition of CRAC current was not an unspecific, toxic effect, as inward rectifier K+ and MagNuM currents of the mast cells were not significantly affected by these N-CaT1 fragments. The shortest N154-CaT1 fragment inhibited CaT1-derived currents in mast cells, but failed to inhibit CRAC currents. Thus, the structural requirements of rCaT N-terminal fragments for inhibition of rCaT1 and CRAC channels are different. These results together with the lack of CaT1 antisense and siRNA effects on currents render it unlikely that CaT1 is a component of native CRAC channels in mast cells. The data further demonstrate a novel strategy for CRAC current inhibition by an N-terminal structure of CaT1.
(Received 11 February 2004;
accepted after revision 11 March 2004;
first published online 12 March 2004)
Corresponding author C. Romanin: Institute for Biophysics, University of Linz, Altenbergerstr. 69, A-4040 Linz, Austria. Email: christoph.romanin{at}jku.at
This article has been cited by other articles:
![]() |
E. Shumilina, R. S. Lam, F. Wolbing, N. Matzner, I. M. Zemtsova, M. Sobiesiak, H. Mahmud, U. Sausbier, T. Biedermann, P. Ruth, et al. Blunted IgE-Mediated Activation of Mast Cells in Mice Lacking the Ca2+-Activated K+ Channel KCa3.1 J. Immunol., June 15, 2008; 180(12): 8040 - 8047. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bolanz, M. A. Hediger, and C. P. Landowski The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther., February 1, 2008; 7(2): 271 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Derler, M. Hofbauer, H. Kahr, R. Fritsch, M. Muik, K. Kepplinger, M. E. Hack, S. Moritz, R. Schindl, K. Groschner, et al. Dynamic but not constitutive association of calmodulin with rat TRPV6 channels enables fine tuning of Ca2+-dependent inactivation J. Physiol., November 15, 2006; 577(1): 31 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Feske, M. Prakriya, A. Rao, and R. S. Lewis A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients J. Exp. Med., September 6, 2005; 202(5): 651 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roos, P. J. DiGregorio, A. V. Yeromin, K. Ohlsen, M. Lioudyno, S. Zhang, O. Safrina, J. A. Kozak, S. L. Wagner, M. D. Cahalan, et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function J. Cell Biol., May 9, 2005; 169(3): 435 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius Store-Operated Ca2+ Entry Channels: Still Elusive! Sci. Signal., July 27, 2004; 2004(243): pe36 - pe36. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. V. Abeele, L. Lemonnier, S. Thebault, G. Lepage, J. B. Parys, Y. Shuba, R. Skryma, and N. Prevarskaya Two Types of Store-operated Ca2+ Channels with Different Activation Modes and Molecular Origin in LNCaP Human Prostate Cancer Epithelial Cells J. Biol. Chem., July 16, 2004; 279(29): 30326 - 30337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |